Applied Therapeutics Inc (NASDAQ:APLT) shares, rose in value on Wednesday, November 20, with price up by 5.60% to the previous day’s close as strong demand from buyers drove the stock to $9.43.
Actively observing the price movement in the last trading, the stock closed the session at $8.93, falling within a range of $8.82 and $9.86. The value of beta (5-year monthly) was 2.018. Referring to stock’s 52-week performance, its high was $10.62, and the low was $1.79. On the whole, APLT has fluctuated by 8.14% over the past month.
With the market capitalization of Applied Therapeutics Inc currently standing at about $1.10 billion, investors are eagerly awaiting this quarter’s results, scheduled for in December.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 183.33k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that APLT’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of APLT currently trading nearly 2.59% and 12.22% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 56.49, while the 7-day volatility ratio is showing 6.91% which for the 30-day chart, stands at 6.90%. Furthermore, Applied Therapeutics Inc (APLT)’s beta value is 2.01, and its average true range (ATR) is 0.63.
A comparison of Applied Therapeutics Inc (APLT) with its peers suggests the former has fared considerably weaker in the market. APLT showed an intraday change of 5.60% in last session, and over the past year, it grew by 373.87%%.
Data on historical trading for Applied Therapeutics Inc (NASDAQ:APLT) indicates that the trading volumes over the past 10 days have averaged 1.91 and over the past 3 months, they’ve averaged 2.66 million. According to company’s latest data on outstanding shares, there are 116.36 million shares outstanding.
Nearly 25.33% of Applied Therapeutics Inc’s shares belong to company insiders and institutional investors own 86.86% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 12.14 million shares as on 2024-10-31, resulting in a short ratio of 7.18. According to the data, the short interest in Applied Therapeutics Inc (APLT) stood at 1165.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 12.36 million. The stock has risen by 181.49% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the APLT stock heading into the next quarter.
